So far, it has been recognized that the concept of combined targeting of gut hormone receptors is also working in humans [1, 2]
MT-1 in subcutaneous implant formulation and documented significant increases in pain-free sun exposure time in EPP patients, with studies characterising reduced phototoxic reactions, improved quality of life, and clinically meaningful photoprotection in a patient population where even brief visible light exposure produces severe phototoxic pain
Prolaktinanstieg Der Anstieg von Prolaktin mit den bekannten unmittelbar auftretenden Nebenwirkungen sexuelle Dysfunktion (Libido-, Erregungs- und Orgasmusstrungen [5], Amenorrh oder Milchfluss tritt vor allem bei Antipsychotika mit relevanter dopaminerger Blockade auf
Moreover, they are resistant to DPP-4 activity and have a longer half-life than native GLP-1
This multi-target approach is believed to support broader metabolic effects than single-target agents